Label: ZENTRIP MOTION SICKNESS- meclizine hydrochloride tablet

  • NDC Code(s): 49873-805-01
  • Packager: Sato Pharmaceutical Co., LTD
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 3, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Meclizine hydrochloride 25mg

  • Purpose

    Antiemetic

  • Uses

    • for the prevention and treatment of the nausea, vomiting, or dizziness associated with motion sickness
  • Warnings

    Do not use in children under 12 years of age unless directed by a physician

    Ask a doctor before use if you have

    • glaucoma
    • a breathing problem such as emphysema or chronic bronchitis
    • difficulty in urination due to enlargement of the prostate gland

    Ask a physician or pharmacist before use if you are

    • taking sedatives or tranquilizers

    When using this product

    • you may get drowsy
    • be careful when driving a motor vehicle or operating machinery
    • alcohol, sedatives, and tranquilizers may increase the drowsiness effect
    • avoid alcoholic beverages

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • to prevent motion sickness, take it at least one hour before traveling
    • adults and children 12 years of age and over: take 1 to 2 tablets (25 to 50mg) once daily, or as directed by a physician.
  • Other information

    • store at 20-30°C (68-86°F)
  • Inactive ingredients

    acesulfame potassium, erythritol, hydroxypropyl cellulose, mannitol, menthol, silicon dioxide colloidal, sodium stearyl fumarate, and yellow ferric oxide.

  • ZenTrip Motion Sickness - 12Tablets

    ZenTrip Motion Sickness - 12Tablets

  • INGREDIENTS AND APPEARANCE
    ZENTRIP MOTION SICKNESS 
    meclizine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49873-805
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)  
    MANNITOL (UNII: 3OWL53L36A)  
    MENTHOL (UNII: L7T10EIP3A)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    ERYTHRITOL (UNII: RA96B954X6)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)  
    HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  
    Product Characteristics
    ColoryellowScorescore with uneven pieces
    ShapeROUNDSize13mm
    FlavorImprint Code SJ
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49873-805-012 in 1 BOX05/01/2021
    16 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00905/01/2021
    Labeler - Sato Pharmaceutical Co., LTD (690575642)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sato Pharmaceutical Co., LTD715699133manufacture(49873-805) , pack(49873-805) , label(49873-805)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!